The PDX Model market was valued at USD 177.32 million in 2022, with a projected growth rate of 13.8% from 2023 to 2029, reaching nearly USD 438.29 million.
Market Overview
As of the most recent PDX Model Market update, the global economic landscape reflects a dynamic interplay of various factors. Major financial markets continue to navigate the aftermath of the unprecedented events that unfolded in recent years, such as the global pandemic and geopolitical shifts. Equities have demonstrated resilience amid ongoing uncertainties, propelled by technological advancements, innovation, and accommodative monetary policies. However, challenges persist, including inflationary pressures, supply chain disruptions, and regulatory changes in various sectors. Investors are closely monitoring central bank decisions, fiscal policies, and emerging trends to assess potential opportunities and risks. The market’s response to evolving conditions underscores the importance of adaptability and strategic planning for both businesses and investors in this complex and ever-changing environment.
Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/162720
Report Scope:
The report provides a comprehensive analysis of the Patient-Derived Xenograft (PDX) Model market, focusing on market size, growth potential, key drivers, restraints, segmentation by type and tumor type, regional insights, and future trends.
Research Methodology:
The research methodology employed for this report involves a combination of primary and secondary research techniques, including extensive data gathering from industry experts, market participants, and reliable databases to ensure accuracy and reliability of the findings.
Key Drivers:
- Rising demand for personalized medication
- Increased R&D efforts in the pharmaceutical industry
- Ongoing governmental and private sector support for cancer research
Restraints:
The high cost of tailored PDX models is expected to restrain market growth throughout the forecast period.
Segmentation:
- By Type: Mice Model segment dominated the market in 2022 due to simplicity of acquisition, ease of manipulation, and lower facility needed for maintenance.
- By Tumor Type: Respiratory Tumor Model held the largest market share in 2022 and is expected to grow at a CAGR of 12.8% during the forecast period.
by Type
Mice Models
Rat Models
by Tumor Type
Gastrointestinal Tumor Models
Gynecological Tumor Models
Respiratory Tumor Models
Urological Tumor Models
Hematological Tumor Models
Other Tumor Models
by Application
Preclinical Drug Development
Biomarker Analysis
Basic Cancer Research
by End-User
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutions
Regional Insights:
- North America dominated the market in 2022 and is expected to grow at a CAGR of 13.2% during the forecast period, driven by rising funding initiatives, awareness among patients regarding personalized medicine, and increased preclinical activities by pharmaceutical companies.
- Europe and the United States are witnessing the development of large-scale PDX libraries for drug development and biomarker screening, further boosting market growth.
Market Key Players
1. JSR Corporation
2. WuXi AppTec
3. Champions Oncology, Inc.
4. THE JACKSON LABORATORY
5. Charles River Laboratories
6. Oncodesign
7. Envigo
8. Pharmatest Services
9. Hera BioLabs
10. EPO Berlin-Buch GmbH
11. Xentech
12. Urosphere
13. Abnova Corporation
14. Genesis Biotechnology Group
15. Explora BioLabs
16. Biocytogen
17. Living Tumor Laboratory
18. Bioduro
19. Aragen Life Sciences w.e.f,
20. Shanghai Lide Biotech Co., Ltd.
21. Certis Oncology Solutions
22. InnoSer
23. IVRS AB
24. BEIJING IDMO Co. Ltd.
25. Shanghai ChemPartner Co., Ltd.
Get to Know More About This Market Study:https://www.maximizemarketresearch.com/market-report/pdx-model-market/162720/
Key questions answered in the PDX Model Market report include:
What is PDX Model?
What factors drive PDX Model Market growth?
What are the main challenges for PDX Model Market growth?
What was the PDX Model market size in 2023?
Which trends are expected to contribute to PDX Model market growth?
What recent industry trends can generate additional revenue streams for the PDX Model Market?
What growth strategies are players considering to increase their foothold in the PDX Model Market?
Who held the largest market share in the PDX Model Market?
Key Offerings:
Past Market Size and Competitive Landscape (2021 to 2023)
Past Pricing and price curve by region (2021 to 2023)
Market Size, Share, Size & Forecast by different segment | 2023−2029
Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
Market Segmentation – A detailed analysis by segment with their sub-segments and Region
Competitive Landscape – Profiles of selected key players by region from a strategic perspective
Competitive landscape – Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER’s analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, IndiaC
+91 96071 95908, +91 9607365656
